SLC22A18 Antibody - N-terminal region
Artikelnummer:
ASB-ARP43825_P050
- Bilder (3)
| Artikelname: | SLC22A18 Antibody - N-terminal region |
| Artikelnummer: | ASB-ARP43825_P050 |
| Hersteller Artikelnummer: | ARP43825_P050 |
| Alternativnummer: | ASB-ARP43825_P050-25UL,ASB-ARP43825_P050-100UL |
| Hersteller: | Aviva |
| Wirt: | Rabbit |
| Kategorie: | Proteine/Peptide |
| Applikation: | WB |
| Spezies Reaktivität: | Bovine, Equine, Guinea pig, Human, Mouse, Rat |
| Immunogen: | The immunogen is a synthetic peptide directed towards the N terminal region of human SLC22A18 |
| Alternative Synonym: | HET, ITM, BWR1A, IMPT1, TSSC5, ORCTL2, BWSCR1A, SLC22A1L, p45-BWR1A |
| This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region as well as the transport of chloroquine- and quinidine-related compounds in the kidney.This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region as well as the transport of chloroquine- and quinidine-related compounds in the kidney. Two alternative transcripts encoding the same isoform have been described. |
|
|
WB Suggested Anti-SLC22A18 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:312500 Positive Control: HepG2 cell lysateSLC22A18 is supported by BioGPS gene expression data to be expressed in HepG2 |
|
|
Host: Rabbit Target Name: SLC22A18 Sample Type: Human Fetal Lung Antibody Dilution: 1.0ug/ml |
|
|
SLC22A18 antibody - N-terminal region (ARP43825_P050) in Human HepG2 using Western Blot |
Produktgarantie und fachkundiger Support
